Secondly, we interrogated whether Jmjd1c is necessary for Jak2V617F-driven MPN disease initiation by introducing Jak2V617F into a Jmjd1c-deficient background, perhaps already adapted to this deficiency. The gene discussed is JMJD1C; the disease is myeloproliferative neoplasm.